Novel biomarkers associated with thoracic aortic disease.

Carlijn G E ThijssenSilvy DekkerLidia R BonsLaurie W GeenenArjen L GökalpJohanna J M TakkenbergMostafa M MokhlesJos A BekkersEric BoersmaElke BouwensRoland R J van KimmenadeJolien W Roos-Hesselink

Published in: International journal of cardiology (2023)

Among a broad range of biomarkers, MMP-3 and IGFBP-2 were associated with disease severity in TAD patients. The pathophysiological pathways uncovered by these biomarkers, and their potential clinical use warrants further research.

Keyphrases

end stage renal disease
ejection fraction
peritoneal dialysis
prognostic factors
spinal cord injury
patient reported outcomes
risk assessment
pulmonary hypertension
human health
pulmonary arterial hypertension
cell migration